[6] [7] Clinical trials evaluating semaglutide safety and efficacy have included participants taking various cardiovascular medications, including anticoagulants and antiplatelet agents
We observed a lower stroke risk among patients initiated GLP-1RA than DPP4 inhibitors (HR: 0.65, 95% CI: 0.600.71), which is consistent with existing evidence
EllieMD is part of an explosion of telehealth companies marketing compounded GLP-1 medications
[1] [3] Clinical trials have examined the incidence of various cancer types in patients receiving GLP-1-based therapies
Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, et al
That combination moves the body away from chronic overeating cues and toward more responsive satiety signaling